CareDx

Our mission to be a leader in diagnostic testing is achieved by providing physicians and their patients with superior quality, service, and value. We are committed to providing excellence through advanced techniques which meet clinician needs and optimize individualized patient care. Our expedited service and instant access allows physicians to provide adequate time to explore treatment options.

We harness the power of our network of companies to deliver comprehensive solutions across the transplant spectrum. We empower patients and providers to make informed decisions about current treatments and future therapies. Eurofins Transplant Diagnostics is the go-to for pre-transplant testing solutions.

Our mission is clear: to provide accurate, timely, and compassionate clinical testing services that empower individuals, healthcare professionals, and organizations to make informed decisions about health and wellness. AccessibilityWe are committed to making our services accessible to everyone. With a rich history of service excellence and a forward-thinking approach, we’ve become a trusted name in the clinical laboratory industry. We believe in the power of knowledge and its potential to transform lives. Our team’s dedication to precision ensures that every result we deliver is reliable and trustworthy. InnovationWe embrace the latest advancements in technology and research to offer cutting-edge diagnostic solutions. We work to keep our prices competitive and collaborate with insurance providers to ensure affordability. Behind every accurate diagnosis and precise result is a dedicated team of experts.

At DiaCarta, our mission is to improve the lives of cancer patients through innovative precision diagnostics. We are committed to providing accurate, reliable, and affordable diagnostics that help physicians make informed treatment decisions. Patient-Centric operations: Our mission is to provide innovative and affordable solutions for cancer patient management, and we prioritize the needs of patients and their families in everything we do. Innovation: We are committed to advancing precision diagnostics and improving patient outcomes through cutting-edge research and development. Continuous Improvement: We are dedicated to ongoing improvement and innovation, and we invest in the development of our team, our products, and our infrastructure to better serve our customers and achieve our mission. We are committed to designing and manufacturing products with the good of the patient in mind. DiaCarta’s RadTox™ Test to Monitor Tumor Response Receives Medicare Coverage. DiaCarta Announces Successful Completion of Oncuria® Validation Study with Nonagen Bioscience.

We are confident of our capabilities and our customer service excellence. We are dealing with your enquiry and one of our Management Team will get back to you as soon as possible to discuss your requirements. BAG Diagnostics have developed a range of products in the fields of Transplantatio & Transfusion Diagnostics, Human Genetics & Infectiology. The CareDx range of NGS products allow pre-transplant HLA Typing and post transplant surveillance of dd-cfDNA after solid organ transplant and chimerism detection after stem cell transplantation. MC Diagnostics is a specialist molecular diagnostics company with expertise in the automation of multiplexed molecular assays and custom designed image analysis and interpretation software. The ALDAS HLA ADR test is a molecular in vitro diagnostic test for the identification of specific HLA alleles. MC Diagnostics is a specialist molecular diagnostics company with expertise in the automation of multiplexed molecular assays and custom designed image analysis and interpretation software.. MC Diagnostics is an innovative molecular diagnostics company.

Our mission is to restore hope by speeding the development of innovative diagnostics and effective treatments to improve care. We believe that the passing of time should increase the joy of the patient and their loved ones, rather than extinguish it. At Discovery, we commit to acquire the leading technologies, employ the most dedicated and brightest minds from every culture, walk of life, and region of the world. Discovery offers the world’s largest commercial biospecimen inventory and procurement network and preeminent multi-omic service laboratories – all to accelerate precision medicine programs for cancer, infectious disease, and other complex conditions. Leading biopharma, diagnostic, and academic institutions trust us to quickly deliver high-quality biospecimens and associated clinical data as well as reliable, reproducible biomarker data – so they can push the leading edge of innovation. Discovery advances science in an innovative, collaborative, and client-centric environment. Our experts are driven to push the boundaries of research and precision medicine programs. Versatile proteomic services conducted by experts to deliver sensitive, reliable, and quantitative results.